These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 31340683)

  • 1. Pharmacodynamics of current and emerging treatments for cervical cancer.
    Duenas-Gonzalez A; Gonzalez-Fierro A
    Expert Opin Drug Metab Toxicol; 2019 Aug; 15(8):671-682. PubMed ID: 31340683
    [No Abstract]   [Full Text] [Related]  

  • 2. Emerging drugs for the treatment of cervical cancer.
    Serrano-Olvera A; Cetina L; Coronel J; Dueñas-González A
    Expert Opin Emerg Drugs; 2015 Jun; 20(2):165-82. PubMed ID: 25578210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety of drug treatments for cervical cancer.
    Dueñas-González A; Cetina L; Coronel J; González-Fierro A
    Expert Opin Drug Saf; 2016; 15(2):169-80. PubMed ID: 26650333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The guidelines for diagnostics and treatment of cervical cancer].
    Inciūra A; Juozaityte E
    Medicina (Kaunas); 2004; 40(4):394-403. PubMed ID: 15111756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating Chemotherapy in the Management of Cervical Cancer: A Critical Appraisal.
    Kumar L; Gupta S
    Oncology; 2016; 91 Suppl 1():8-17. PubMed ID: 27464068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weekly cisplatin therapy compared with triweekly combination chemotherapy as concurrent adjuvant chemoradiation therapy after radical hysterectomy for cervical cancer.
    Lee HN; Lee KH; Lee DW; Lee YS; Park EK; Park JS
    Int J Gynecol Cancer; 2011 Jan; 21(1):128-36. PubMed ID: 21330837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New pharmacotherapy options for cervical cancer.
    Dueñas-Gonzalez A; Cetina L; Coronel J; Cano C; Dolores R
    Expert Opin Pharmacother; 2014 Jan; 15(1):51-60. PubMed ID: 24206031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
    Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pelvic radiation with concurrent chemotherapy compared with pelvi and para-aortic radiation for high-risk cervical cancer. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. Cisplatin, radiation, and adjuvant hysterectomy for bulky stage Ib cervical carcinoma].
    Nöel G; Mazeron JJ
    Cancer Radiother; 1999; 3(4):345-7. PubMed ID: 10515699
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase I Dose-Escalation Study of Weekly Paclitaxel and Cisplatin Followed by Radical Hysterectomy in Stages IB2 and IIA2 Cervical Cancer.
    Chou HH; Huang HJ; Lin H; Yang LY; Hsueh S; Liu FY; Liou YL; Liou JD; Chen MY; Chao A; Lin G; Chang TC; Lai CH
    Am J Clin Oncol; 2017 Jun; 40(3):241-249. PubMed ID: 25350466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer.
    Angioli R; Plotti F; Montera R; Aloisi A; Luvero D; Capriglione S; Terranova C; De Cicco Nardone C; Muzii L; Benedetti-Panici P
    Gynecol Oncol; 2012 Nov; 127(2):290-6. PubMed ID: 22819938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modern management of locally advanced cervical carcinoma.
    Dueñas-Gonzalez A; Cetina L; Mariscal I; de la Garza J
    Cancer Treat Rev; 2003 Oct; 29(5):389-99. PubMed ID: 12972357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative analysis of neoadjuvant therapies in stage Ib2 and IIa2 cervical carcinoma].
    Hu JL; Wu LY; Li N; Li XG; Huang MN; Zhang R
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):452-7. PubMed ID: 22932113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy in the management of cervical carcinoma.
    duPont NC; Monk BJ
    Clin Adv Hematol Oncol; 2006 Apr; 4(4):279-86. PubMed ID: 16728939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemotherapy followed by robotic radical hysterectomy in locally advanced cervical cancer: a multi-institution study.
    Vizza E; Corrado G; Zanagnolo V; Tomaselli T; Cutillo G; Mancini E; Maggioni A
    Gynecol Oncol; 2014 May; 133(2):180-5. PubMed ID: 24589412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy versus radiotherapy for FIGO stages IB1 and IIA1 cervical carcinoma patients with postoperative isolated deep stromal invasion: a retrospective study.
    Li L; Song X; Liu R; Li N; Zhang Y; Cheng Y; Chao H; Wang L
    BMC Cancer; 2016 Jul; 16():403. PubMed ID: 27387204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of chemotherapy in locally advanced, metastatic and recurrent cervical cancer.
    Tambaro R; Scambia G; Di Maio M; Pisano C; Barletta E; Iaffaioli VR; Pignata S
    Crit Rev Oncol Hematol; 2004 Oct; 52(1):33-44. PubMed ID: 15363465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study.
    Ferrandina G; Palluzzi E; Gallotta V; Gambacorta MA; Autorino R; Turco LC; Macchia G; Cosentino F; Gui B; Mattoli MV; Ronzino G; Valentini V; Scambia G
    Eur J Surg Oncol; 2018 Jul; 44(7):1062-1068. PubMed ID: 29753611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinational therapies for the treatment of advanced cervical cancer.
    Duenas-Gonzalez A
    Expert Opin Pharmacother; 2023 Jan; 24(1):73-81. PubMed ID: 35653267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-institutional phase II study of neoadjuvant irinotecan and nedaplatin followed by radical hysterectomy and the adjuvant chemotherapy for locally advanced, bulky uterine cervical cancer: A Kansai Clinical Oncology Group study (KCOG-G1201).
    Mori T; Makino H; Okubo T; Fujiwara Y; Sawada M; Kuroboshi H; Tsubamoto H; Murakoshi H; Motohashi T; Kitawaki J; Ito K
    J Obstet Gynaecol Res; 2019 Mar; 45(3):671-678. PubMed ID: 30575239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.